Work

The impact of IDH mutation and 1p/19q codeletion on immune-checkpoint inhibitor efficacy in recurrent gliomas.

Year: 2025

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.2053

Authors: Shameel Shafqat, Muhammad Asad Maqbool, Terence C Burns, Jian Li Campian, Shannon Patricia Fortin Ensign, Evanthia Galanis, Julie Elaine Hammack, Maciej Mrugala, Bryan Neth, Alyx B. Porter, Michael W. Ruff, Ugur Sener, Wendy Joyce Sherman, Joon H. Uhm, Sani Haider Kizilbash

Institutions: Mayo Clinic, Mayo Clinic Comprehensive Cancer Center (Minnesota), Mayo Clinic Hospital, Mayo Clinic in Florida, Mayo Clinic in Arizona

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410817175

Cites:

Cited by:

Related to: 10